| [1] | Simakou T, Butcher JP, Reid S, et al. Alopecia areata: a multifactorial autoimmune condition[J]. J Autoimmun, 2019,98:74⁃85. doi: 10.1016/j.jaut.2018.12.001. | 
																													
																						| [2] | Bertolini M, McElwee K, Gilhar A, et al. Hair follicle immune privilege and its collapse in alopecia areata[J]. Exp Dermatol, 2020,29(8):703⁃725. doi: 10.1111/exd.14155. | 
																													
																						| [3] | Celik SD, Ates O. Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata[J]. J Clin Lab Anal, 2018,32(5):e22386. doi: 10.1002/jcla.22386. | 
																													
																						| [4] | Song T, Guttman⁃Yassky E. Alopecia areata: a complex cytokine driven disease[J]. J Investig Dermatol Symp Proc, 2020,20(1):S55⁃S57. doi: 10.1016/j.jisp.2020.04.007. | 
																													
																						| [5] | Sherratt S, Patel A, Baker DA, et al. Differential IL⁃18 dependence of canonical and adaptive NK cells for antibody dependent responses to P. falciparum[J]. Front Immunol, 2020,11:533. doi: 10.3389/fimmu.2020.00533. | 
																													
																						| [6] | 赵鹏, 秦小卫, 秦俊霞, 等. 斑秃患者外周血白细胞介素35的表达及其对调节性T细胞的功能调控[J]. 中华皮肤科杂志, 2022,55(3):224⁃230. doi: 10.35541/cjd.20210653. | 
																													
																						| [7] | 梁海军, 崔艳慧, 王燕平, 等. 基质金属蛋白酶对MRSA脓毒症患者NK细胞的调控作用[J]. 中华急诊医学杂志, 2020,29(6):835⁃840. doi: 10.3760/cma.j.issn.1671⁃0282.2020.06.019. | 
																													
																						| [8] | Kucuksezer UC, Aktas Cetin E, Esen F, et al. The role of natural killer cells in autoimmune diseases[J]. Front Immunol, 2021,12:622306. doi: 10.3389/fimmu.2021.622306. | 
																													
																						| [9] | Park IH, Yang HN, Lee KJ, et al. Tumor⁃derived IL⁃18 induces PD⁃1 expression on immunosuppressive NK cells in triple⁃negative breast cancer[J]. Oncotarget, 2017,8(20):32722⁃32730. doi: 10.18632/oncotarget.16281. | 
																													
																						| [10] | Zhang C, Tian Z. NK cell subsets in autoimmune diseases[J]. J Autoimmun, 2017,83:22⁃30. doi: 10.1016/j.jaut.2017.02.005. | 
																													
																						| [11] | Zitti B, Bryceson YT. Natural killer cells in inflammation and autoimmunity[J]. Cytokine Growth Factor Rev, 2018,42:37⁃46. doi: 10.1016/j.cytogfr.2018.08.001. | 
																													
																						| [12] | Lutz G, Niedecken H, Bauer R, et al. Natural killer cell and cytotoxic/suppressor T cell deficiency in peripheral blood in subjects with alopecia areata[J]. Australas J Dermatol, 1988,29(1):29⁃32. doi: 10.1111/j.1440⁃0960.1988.tb01222.x. | 
																													
																						| [13] | Ghraieb A, Keren A, Ginzburg A, et al. iNKT cells ameliorate human autoimmunity: lessons from alopecia areata[J]. J Autoimmun, 2018,91:61⁃72. doi: 10.1016/j.jaut.2018.04.001. | 
																													
																						| [14] | Le Duff F, Bouaziz JD, Fontas E, et al. Low⁃dose IL⁃2 for treating moderate to severe alopecia areata: a 52⁃week multicenter prospective placebo⁃controlled study assessing its impact on T regulatory cell and NK cell populations[J]. J Invest Dermatol, 2021,141(4):933⁃936.e6. doi: 10.1016/j.jid.2020.08. 015. | 
																													
																						| [15] | Tremblay⁃McLean A, Coenraads S, Kiani Z, et al. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function[J]. BMC Immunol, 2019,20(1):8. doi: 10.1186/s12865⁃018⁃0272⁃x. | 
																													
																						| [16] | Wagstaffe HR, Clutterbuck EA, Bockstal V, et al. Antibody⁃dependent natural killer cell activation after ebola vaccination[J]. J Infect Dis, 2021,223(7):1171⁃1182. doi: 10.1093/infdis/jiz657. | 
																													
																						| [17] | Vecchié A, Bonaventura A, Toldo S, et al. IL⁃18 and infections: Is there a role for targeted therapies?[J]. J Cell Physiol, 2021,236(3):1638⁃1657. doi: 10.1002/jcp.30008. | 
																													
																						| [18] | Zhou T, Damsky W, Weizman OE, et al. IL⁃18BP is a secreted immune checkpoint and barrier to IL⁃18 immunotherapy[J]. Nature, 2020,583(7817):609⁃614. doi: 10.1038/s41586⁃020⁃2422⁃6. | 
																													
																						| [19] | Kim SK, Park HJ, Chung JH, et al. Association between interleukin 18 polymorphisms and alopecia areata in Koreans[J]. J Interferon Cytokine Res, 2014,34(5):349⁃353. doi: 10. 1089/jir.2013.0055. | 
																													
																						| [20] | Lee D, Hong SK, Park SW, et al. Serum levels of IL⁃18 and sIL⁃2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids[J]. Exp Dermatol, 2010,19(2):145⁃147. doi: 10.1111/j.1600⁃0625.2009.00937.x. | 
																													
																						| [21] | Choi YH, Lim EJ, Kim SW, et al. IL⁃27 enhances IL⁃15/IL⁃18⁃mediated activation of human natural killer cells[J]. J Immunother Cancer, 2019,7(1):168. doi: 10.1186/s40425⁃019⁃0652⁃7. | 
																													
																						| [22] | Oka N, Markova T, Tsuzuki K, et al. IL⁃12 regulates the expansion, phenotype, and function of murine NK cells activated by IL⁃15 and IL⁃18[J]. Cancer Immunol Immunother, 2020,69(9):1699⁃1712. doi: 10.1007/s00262⁃020⁃02553⁃4. | 
																													
																						| [23] | Lee KM, Kang JH, Yun M, et al. Quercetin inhibits the poly (dA:dT)⁃induced secretion of IL⁃18 via down⁃regulation of the expressions of AIM2 and pro⁃caspase⁃1 by inhibiting the JAK2/STAT1 pathway in IFN⁃γ⁃primed human keratinocytes[J]. Biochem Biophys Res Commun, 2018,503(1):116⁃122. doi: 10. 1016/j.bbrc.2018.05.191. |